You are here

eye disease

AbbVie and Capsida Biotherapeutics partner on eye disease focused gene therapies

Biopharma Reporter

Mon, 02/27/23 - 09:59 am

Capsida Biotherapeutics

drug development

AbbVie, Capsida Set Sights on Gene Therapies for Eye Diseases

BioSpace

Thu, 02/23/23 - 10:02 am

Capsida Biotherapeutics

Merck & Co. bails on NGM eye disease collab in wake of phase 2 fail

Fierce Biotech

Wed, 12/21/22 - 11:29 am

NGM Biopharmaceuticals

clinical trials

geographic atrophy

Apellis Pharmaceuticals Surges On New Review Date For Eye-Disease Treatment

Investors Business Daily

Fri, 11/18/22 - 11:30 am

Apellis Pharmaceuticals

geographic atrophy

Hovione's drug delivery tech lands eye disease licensing deal

Fierce Pharma

Tue, 05/10/22 - 10:51 am

Ji Xing Pharmaceuticals

Another Oxurion eye disease drug flunks phase 2, leaving biotech all-in on last prospect

Fierce Biotech

Mon, 05/9/22 - 10:03 am

Intellia looks to eye diseases in latest deal

BioPharma Dive

Wed, 10/13/21 - 10:38 pm

Intellia Therapeutics

Can a topical treatment beat blockbuster eye injectables? A Swiss biotech has the cash now to find out

Endpoints

Tue, 05/4/21 - 10:50 am

Unity Bio Restructuring Cuts 30% of Staff, Keeps Focus on Eye Drug

Xconomy

Tue, 09/15/20 - 11:03 am

Unity Biotechnology

Biogen boosts gene therapy strategy with Harvard pact focused on inherited eye disease

Fierce Biotech

Mon, 07/6/20 - 12:00 pm

AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis

Xconomy

Wed, 06/24/20 - 10:14 am

AsclepiX Therapeutics

wet age-related macular degeneration

retinal occulsion

Novartis Considers Offer for Takeda Eye-Disease Assets

Bloomberg

Wed, 05/8/19 - 05:25 pm

How this biotech plans to go up against big pharma with its eye disease products

Drug Delivery Business News

Sat, 12/30/17 - 10:38 am

Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases

Yahoo

Thu, 03/24/16 - 09:56 am

Biogen enters eye-treatment arena with AGTC deal

Yahoo/Reuters

Thu, 07/2/15 - 11:18 am

Bayer bets on Johns Hopkins for eye disease R&D

Fierce Biotech

Tue, 06/16/15 - 12:01 pm

Two Promising Gene Therapy Stocks Tackling Eye Disease

TheStreet.com

Tue, 09/9/14 - 10:15 am

Applied Genetic Technologies

Avalanche Biotechnologies

IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery

Thu, 07/29/10 - 03:25 pm

Otsuka Pharma extends research collaboration with MethylGene

Pharmabiz

Sat, 07/3/10 - 10:50 am

Alcon Boosts Presence In Eye Disease Market

Yahoo/Investors Business Daily

Mon, 11/9/09 - 10:01 am